InvestorsHub Logo
Followers 8
Posts 281
Boards Moderated 0
Alias Born 06/26/2016

Re: longfellow95 post# 298030

Sunday, 08/02/2020 9:30:03 AM

Sunday, August 02, 2020 9:30:03 AM

Post# of 721109
Here is what Dr. Liau had to say regarding the subject.

So, with a DC vaccine, like I said, we can just make it ourselves. We can’t scale up as an academic institution or a small company, but if that were part of the company we could scale up. To make the vaccine, you just need a manufacturing GMP facility. But the problem there is the autologous dendritic cells are hard to get patented. You could patent it, but it’s hard to defend that because it’s really the patient’s own tumor, right?

So, the patents really are process patents and we could file one that tweaks things a little bit, and that’s essentially that’s what Northwest Bio did. They filed multiple patents just on little tweaks of the cocktails that are used to make the cells.

https://billmalloy.info/qa-with-linda-liau/

For some reason this has always troubled me a bit, but this latest thread has eased my mind a bit. Thanks for all the insight.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News